{"title":"IgD-CD38-B细胞上的CD27介导粪球菌与copd的联系。","authors":"Yaning Gao, Liang Chen, Jianhong Zhang, Zhengjun Wen","doi":"10.2147/COPD.S518455","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The gut-lung axis, representing the communication between gut microbiota and the lungs, has been hypothesized to influence chronic obstructive pulmonary disease (COPD) development through modulation of the immune response. However, the causal role of gut microbiota in COPD and the potential mediating role of immune cells remain largely undetermined. This study aimed to uncover the causal relationship between gut microbiota and COPD and explore the potential mediating role of immune cells in this connection.</p><p><strong>Methods: </strong>This study employed a two-step Mendelian randomization (MR) analysis to investigate the causal effect of gut microbiota on COPD and explore the potential mediating role of immune cells in this relationship. The inverse variance weighted method served as the primary MR analysis method.</p><p><strong>Results: </strong>MR analyses revealed statistically significant genetic associations between 28 gut microbiota and COPD. Among these, the genus <i>Coprococcus</i> demonstrated the strongest causal effect on COPD risk, exhibiting a significant positive association (odds ratio (OR) = 1.18, 95% confidence interval (CI): 1.03-1.36, <i>P</i> = 0.03). Additionally, 15 immune cell traits displayed significant associations with <i>Coprococcus</i>. Notably, CD27 expressed on IgD<sup>-</sup> CD38<sup>-</sup> B cells emerged as a potential contributor to COPD development (OR = 1.04, 95% CI: 1.00-1.07, <i>P</i> = 0.03). We further explored the potential mediating effect of CD27 on IgD<sup>-</sup> CD38<sup>-</sup> B cells in the relationship between <i>Coprococcus</i> and COPD.</p><p><strong>Conclusion: </strong>Our MR analysis provided evidence for a causal association between gut microbiota and COPD, potentially mediated by immune cells.</p>","PeriodicalId":48818,"journal":{"name":"International Journal of Chronic Obstructive Pulmonary Disease","volume":"20 ","pages":"2173-2182"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12232946/pdf/","citationCount":"0","resultStr":"{\"title\":\"CD27 on IgD-CD38-B Cells Mediates the Coprococcus-COPD Link.\",\"authors\":\"Yaning Gao, Liang Chen, Jianhong Zhang, Zhengjun Wen\",\"doi\":\"10.2147/COPD.S518455\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The gut-lung axis, representing the communication between gut microbiota and the lungs, has been hypothesized to influence chronic obstructive pulmonary disease (COPD) development through modulation of the immune response. However, the causal role of gut microbiota in COPD and the potential mediating role of immune cells remain largely undetermined. This study aimed to uncover the causal relationship between gut microbiota and COPD and explore the potential mediating role of immune cells in this connection.</p><p><strong>Methods: </strong>This study employed a two-step Mendelian randomization (MR) analysis to investigate the causal effect of gut microbiota on COPD and explore the potential mediating role of immune cells in this relationship. The inverse variance weighted method served as the primary MR analysis method.</p><p><strong>Results: </strong>MR analyses revealed statistically significant genetic associations between 28 gut microbiota and COPD. Among these, the genus <i>Coprococcus</i> demonstrated the strongest causal effect on COPD risk, exhibiting a significant positive association (odds ratio (OR) = 1.18, 95% confidence interval (CI): 1.03-1.36, <i>P</i> = 0.03). Additionally, 15 immune cell traits displayed significant associations with <i>Coprococcus</i>. Notably, CD27 expressed on IgD<sup>-</sup> CD38<sup>-</sup> B cells emerged as a potential contributor to COPD development (OR = 1.04, 95% CI: 1.00-1.07, <i>P</i> = 0.03). We further explored the potential mediating effect of CD27 on IgD<sup>-</sup> CD38<sup>-</sup> B cells in the relationship between <i>Coprococcus</i> and COPD.</p><p><strong>Conclusion: </strong>Our MR analysis provided evidence for a causal association between gut microbiota and COPD, potentially mediated by immune cells.</p>\",\"PeriodicalId\":48818,\"journal\":{\"name\":\"International Journal of Chronic Obstructive Pulmonary Disease\",\"volume\":\"20 \",\"pages\":\"2173-2182\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12232946/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Chronic Obstructive Pulmonary Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/COPD.S518455\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/COPD.S518455","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
摘要
背景:肠-肺轴,代表肠道微生物群和肺之间的交流,已经被假设通过调节免疫反应来影响慢性阻塞性肺疾病(COPD)的发展。然而,肠道微生物群在COPD中的因果作用以及免疫细胞的潜在介导作用在很大程度上仍未确定。本研究旨在揭示肠道微生物群与COPD之间的因果关系,并探讨免疫细胞在这一联系中的潜在介导作用。方法:本研究采用两步孟德尔随机化(MR)分析来研究肠道微生物群与COPD的因果关系,并探讨免疫细胞在这一关系中的潜在介导作用。方差逆加权法是主要的MR分析方法。结果:MR分析显示28种肠道微生物群与COPD之间具有统计学意义的遗传关联。其中,Coprococcus属与COPD风险的因果关系最强,呈显著正相关(优势比(OR) = 1.18, 95%可信区间(CI): 1.03-1.36, P = 0.03)。此外,15种免疫细胞性状与粪原球菌有显著相关性。值得注意的是,在IgD- CD38- B细胞上表达的CD27成为COPD发展的潜在因素(OR = 1.04, 95% CI: 1.00-1.07, P = 0.03)。我们进一步探讨了CD27对IgD- CD38- B细胞在Coprococcus与COPD之间的潜在介导作用。结论:我们的MR分析为肠道微生物群和COPD之间的因果关系提供了证据,可能由免疫细胞介导。
CD27 on IgD-CD38-B Cells Mediates the Coprococcus-COPD Link.
Background: The gut-lung axis, representing the communication between gut microbiota and the lungs, has been hypothesized to influence chronic obstructive pulmonary disease (COPD) development through modulation of the immune response. However, the causal role of gut microbiota in COPD and the potential mediating role of immune cells remain largely undetermined. This study aimed to uncover the causal relationship between gut microbiota and COPD and explore the potential mediating role of immune cells in this connection.
Methods: This study employed a two-step Mendelian randomization (MR) analysis to investigate the causal effect of gut microbiota on COPD and explore the potential mediating role of immune cells in this relationship. The inverse variance weighted method served as the primary MR analysis method.
Results: MR analyses revealed statistically significant genetic associations between 28 gut microbiota and COPD. Among these, the genus Coprococcus demonstrated the strongest causal effect on COPD risk, exhibiting a significant positive association (odds ratio (OR) = 1.18, 95% confidence interval (CI): 1.03-1.36, P = 0.03). Additionally, 15 immune cell traits displayed significant associations with Coprococcus. Notably, CD27 expressed on IgD- CD38- B cells emerged as a potential contributor to COPD development (OR = 1.04, 95% CI: 1.00-1.07, P = 0.03). We further explored the potential mediating effect of CD27 on IgD- CD38- B cells in the relationship between Coprococcus and COPD.
Conclusion: Our MR analysis provided evidence for a causal association between gut microbiota and COPD, potentially mediated by immune cells.
期刊介绍:
An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals